BIOLASE, Inc. provided earnings guidance for the year 2024. For the period, the company plans to Grow total full-year 2024 revenue between 6% and 8% to between $52 million and $53 million through the continued adoption of lasers and consumables by the dental community, including general dentists, dental specialists, dental hygienists, and group practice entities (DSOs) Improve loss from operations by 50% to 60% for the full year 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.148 USD | 0.00% | +6.47% | -86.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.81% | 4.92M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- BIOL Stock
- News BIOLASE, Inc.
- BIOLASE, Inc. Provides Earnings Guidance for the Year 2024